Drug manufacturer to launch commercial version of ‘natural painkiller’ Palmitoylethanolamide (PEA)

A large U.S. pharmaceutical company is preparing to go to market with a mass-produced commercial version of a natural pain management supplement that compounding pharmacies in Australia have been providing to integrative doctors and their patients for many years – Palmitoylethanolamide, or PEA. In November the drug manufacturer, Gencor, announced it had recently completed a 

Continue Reading…

Arthritis sufferers cautioned on using ibuprofen

  Health professionals in Australia are taking notice of a recent European study¹ which has demonstrated a link between ibuprofen and an increased risk of high blood pressure and cardiovascular disease in patients suffering arthritis. The study, released in August of this year by the European Society of Cardiology (ESC), found that patients receiving ibuprofen 

Continue Reading…

Customising medication for better pain management

Health professionals in Australia are taking notice of a recent European study¹ which has demonstrated a link between ibuprofen and an increased risk of high blood pressure and cardiovascular disease in patients suffering arthritis. The study, released in August of this year by the European Society of Cardiology (ESC), found that patients receiving ibuprofen had 

Continue Reading…